Author:
Soltani Fardad,Jenkins David A.,Kaura Amit,Bradley Joshua,Black Nicholas,Farrant John P.,Williams Simon G.,Mulla Abdulrahim,Glampson Benjamin,Davies Jim,Papadimitriou Dimitri,Woods Kerrie,Shah Anoop D.,Thursz Mark R.,Williams Bryan,Asselbergs Folkert W.,Mayer Erik K.,Herbert Christopher,Grant Stuart,Curzen Nick,Squire Iain,Johnson Thomas,O’Gallagher Kevin,Shah Ajay M.,Perera Divaka,Kharbanda Rajesh,Patel Riyaz S.,Channon Keith M.,Lee Richard,Peek Niels,Mayet Jamil,Miller Christopher A.
Abstract
Abstract
Background
Heart failure (HF) with preserved or mildly reduced ejection fraction includes a heterogenous group of patients. Reclassification into distinct phenogroups to enable targeted interventions is a priority. This study aimed to identify distinct phenogroups, and compare phenogroup characteristics and outcomes, from electronic health record data.
Methods
2,187 patients admitted to five UK hospitals with a diagnosis of HF and a left ventricular ejection fraction ≥ 40% were identified from the NIHR Health Informatics Collaborative database. Partition-based, model-based, and density-based machine learning clustering techniques were applied. Cox Proportional Hazards and Fine-Gray competing risks models were used to compare outcomes (all-cause mortality and hospitalisation for HF) across phenogroups.
Results
Three phenogroups were identified: (1) Younger, predominantly female patients with high prevalence of cardiometabolic and coronary disease; (2) More frail patients, with higher rates of lung disease and atrial fibrillation; (3) Patients characterised by systemic inflammation and high rates of diabetes and renal dysfunction. Survival profiles were distinct, with an increasing risk of all-cause mortality from phenogroups 1 to 3 (p < 0.001). Phenogroup membership significantly improved survival prediction compared to conventional factors. Phenogroups were not predictive of hospitalisation for HF.
Conclusions
Applying unsupervised machine learning to routinely collected electronic health record data identified phenogroups with distinct clinical characteristics and unique survival profiles.
Funder
NIHR Imperial Biomedical Research Centre
NIHR Oxford Biomedical Research Centre
NIHR University College London Biomedical Research Centre
National Institute for Health and Care Research
UK Research and Innovation
British Heart Foundation
NIHR Leeds Clinical Research Facility
NIHR Manchester Biomedical Research Centre
NIHR Southampton Biomedical Research Centre
NIHR Leicester Biomedical Research Centre
NIHR Bristol Biomedical Research Centre
British Heart Foundation Centre of Excellence at the School of Cardiovascular Medicine and Sciences, King’s College London
NIHR Biomedical Research Centre at The Royal Marsden and Institute of Cancer Research
BHF Imperial Centre for Research Excellence
Publisher
Springer Science and Business Media LLC